PMID- 10521294 OWN - NLM STAT- MEDLINE DCOM- 19991210 LR - 20200824 IS - 0002-9297 (Print) IS - 0002-9297 (Linking) VI - 65 IP - 5 DP - 1999 Nov TI - Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations. PG - 1291-8 AB - Hereditary nonpolyposis colorectal cancer (HNPCC) (Amsterdam criteria) is often caused by mutations in mismatch repair (MMR) genes, and tumors of patients with HNPCC show microsatellite instability (MSI-high phenotype). Germline mutations of MMR genes have rarely been found in families that have HNPCC or suspected HNPCC and that do not show microsatellite instability (MSI-low phenotype). Therefore, an MSI-high phenotype is often used as an inclusion criterion for mutation testing of MMR genes. Correction of base-base mismatches is the major function of MSH6. Since mismatches present with an MSI-low phenotype, we assumed that the phenotype in patients with HNPCC-related tumors might be associated with MSH6 germline mutations. We divided 36 patients with suspected HNPCC into an MSI-low group (n=18) and an MSI-high group (n=18), on the basis of the results of MSI testing. Additionally, three unrelated patients from Amsterdam families with MSI-low tumors were investigated. All patients were screened for MSH2, MLH1, and MSH6 mutations. Four presumably causative MSH6 mutations were detected in the patients (22%) who had suspected HNPCC and MSI-low tumors. Furthermore, we detected one frameshift mutation in one of the three patients with HNPCC and MSI-low tumors. In the MSI-high group, one MSH6 missense mutation was found, but the same patient also had an MLH1 mutation, which may explain the MSI-high phenotype. These results suggest that MSH6 may be involved in a substantial proportion of patients with HNPCC or suspected HNPCC and MSI-low tumors. Our data emphasize that an MSI-low phenotype cannot be considered an exclusion criterion for mutation testing of MMR genes in general. FAU - Wu, Y AU - Wu Y AD - Departments of Medical Genetics, University of Groningen, Groningen, The Netherlands. FAU - Berends, M J AU - Berends MJ FAU - Mensink, R G AU - Mensink RG FAU - Kempinga, C AU - Kempinga C FAU - Sijmons, R H AU - Sijmons RH FAU - van Der Zee, A G AU - van Der Zee AG FAU - Hollema, H AU - Hollema H FAU - Kleibeuker, J H AU - Kleibeuker JH FAU - Buys, C H AU - Buys CH FAU - Hofstra, R M AU - Hofstra RM LA - eng SI - GENBANK/U73732 SI - GENBANK/U73733 SI - GENBANK/U73734 SI - GENBANK/U73735 SI - GENBANK/U73736 SI - GENBANK/U73737 PT - Journal Article PT - Research Support, Non-U.S. Gov't PL - United States TA - Am J Hum Genet JT - American journal of human genetics JID - 0370475 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Carrier Proteins) RN - 0 (DNA-Binding Proteins) RN - 0 (G-T mismatch-binding protein) RN - 0 (MLH1 protein, human) RN - 0 (Neoplasm Proteins) RN - 0 (Nuclear Proteins) RN - 0 (Proto-Oncogene Proteins) RN - EC 3.6.1.3 (MSH2 protein, human) RN - EC 3.6.1.3 (MutL Protein Homolog 1) RN - EC 3.6.1.3 (MutS Homolog 2 Protein) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Base Pair Mismatch MH - Carrier Proteins MH - Colorectal Neoplasms, Hereditary Nonpolyposis/*genetics MH - DNA Mutational Analysis MH - DNA Repair MH - DNA-Binding Proteins/*genetics MH - Electrophoresis, Gel, Two-Dimensional MH - Exons MH - Female MH - Humans MH - Male MH - Microsatellite Repeats/*genetics MH - Molecular Sequence Data MH - MutL Protein Homolog 1 MH - MutS Homolog 2 Protein MH - Neoplasm Proteins MH - Nuclear Proteins MH - Pedigree MH - Proto-Oncogene Proteins/genetics PMC - PMC1288281 EDAT- 1999/10/16 09:00 MHDA- 2000/03/21 09:00 CRDT- 1999/10/16 09:00 PHST- 1999/10/16 09:00 [pubmed] PHST- 2000/03/21 09:00 [medline] PHST- 1999/10/16 09:00 [entrez] AID - S0002-9297(07)62135-1 [pii] AID - 10.1086/302612 [doi] PST - ppublish SO - Am J Hum Genet. 1999 Nov;65(5):1291-8. doi: 10.1086/302612.